Previous Close | 12.87 |
Open | 12.83 |
Bid | 13.21 x 100 |
Ask | 13.44 x 100 |
Day's Range | 12.83 - 13.64 |
52 Week Range | 7.51 - 18.93 |
Volume | |
Avg. Volume | 101,154 |
Market Cap | 349.743M |
Beta (5Y Monthly) | 1.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.23 |
Earnings Date | Feb 20, 2025 - Feb 24, 2025 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 25.89 |
VALENCIA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a company specializing in commercial-stage regenerative medicine and pioneering devices for wound care management and skin restoration, today announced it has entered into an exclusive distribution agreement with Revolution Surgical Pty Ltd. This agreement marks an important milestone in our expansion into the Australian and New Zealand markets. Under the terms of the agreement, Revolution Surgical
Shareholders of AVITA Medical, Inc. ( NASDAQ:RCEL ) will be pleased this week, given that the stock price is up 16% to...